Comparison of the efficacy and safety of dabigatran and warfarin in patients with atrial fibrillation using data from real world practice

Trial Profile

Comparison of the efficacy and safety of dabigatran and warfarin in patients with atrial fibrillation using data from real world practice

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Sep 2015

At a glance

  • Drugs Dabigatran etexilate (Primary) ; Warfarin
  • Indications Stroke
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Sep 2015 Subgroup analysis; elderly patients ≥75 years (n=15,918) results published in the Thrombosis and Haemostasis.
    • 07 May 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top